Externally regulated programmed aging and effects of population stress on mammal lifespan
- 33 Downloads
Programmed (adaptive) aging refers to the idea that mammals, including humans and other complex organisms, have evolved mechanisms that purposely cause or allow senescence or otherwise internally limit their lifespans in order to obtain an evolutionary advantage. Until recently, programmed aging had been thought to be theoretically impossible because of the mechanics of the evolution process. However, there is now substantial theoretical and empirical support for the existence of programmed aging in mammals. Therefore, a comprehensive approach to medical research on aging and age-related diseases must consider programmed aging mechanisms and the detailed nature of such mechanisms is of major importance. Theories of externally regulated programmed aging suggest that in mammals and other complex organisms, genetically specified senescence mechanisms detect local or temporary external conditions that affect the optimal lifespan for a species population and can adjust the lifespans of individual members in response. This article describes why lifespan regulation in response to external conditions adds to the evolutionary advantage produced by programmed aging and why a specific externally regulated programmed aging mechanism provides the best match to empirical evidence on mammal senescence.
Keywordssenescence evolution gerontology health policy medical research evolvability
Unable to display preview. Download preview PDF.
- 1.Weismann, A. (1882) Uber die Dauer des Lebens, Fischer, Jena.Google Scholar
- 2.Goldsmith, T. (2014) The Evolution of Aging, 3rd Edn., Azinet, Annapolis.Google Scholar
- 4.Skulachev, V. (1997) Aging is a specific biological function rather than the result of a disorder in complex living systems: biochemical evidence in support of Weismann’s hypothesis, Biochemistry (Moscow), 62, 1191.Google Scholar
- 5.Mitteldorf, J. (2006) Chaotic population dynamics and the evolution of ageing, Evol. Ecol. Res., 8, 561–574.Google Scholar
- 6.Goldsmith, T. (2017) Evolvability, population benefit, and the evolution of programmed aging in mammals, Biochemistry (Moscow), 12, 1423–1429.Google Scholar
- 7.Medawar, P. (1952) An Unsolved Problem of Biology, H. K. Lewis & Co., London.Google Scholar
- 8.Wayne-Edwards, V. (1962) Animal Dispersion in Relation to Social Behaviour, Oliver & Boyd, Edinburgh.Google Scholar
- 12.Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., Dutra, A., Pak, E., Durkin, S., Csoka, A. B., Boehnke, M., Glover, T. W., and Collins, F. S. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome, Nature, 423, 293–298.CrossRefPubMedGoogle Scholar
- 15.Robinson, M., Dasari, S., Konopka, A. R., Johnson, M. L., Manjunatha, S., Esponda, R. R., Carter, R. E., Lanza, I. R., and Nair, K. S. (2017) Enhanced protein translation underlies improved metabolic and physical adaptations to different exercise training modes in young and old humans, Cell Metab., 25, 581–592.CrossRefPubMedGoogle Scholar
- 16.Spindler, S., Dasari, S., Konopka, A. R., Johnson, M. L., Manjunatha, S., Esponda, R. R., Carter, R. E., Lanza, I. R., and Nair, K. S. (2005) Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction, Mech. Ageing Dev., 126, 960–966.CrossRefPubMedGoogle Scholar
- 19.Ambrosia LLC (2016) Clinical Trial: Young Donor Plasma Transfusion and Age-Related Biomarkers, NIH identifier: NCT02803554.Google Scholar